Issue 21 - The Cancer Letter

<img class="lazy" src="data:image/svg+xml,%3Csvg%20xmlns='http://www.w3.org/2000/svg'%20viewBox='0%200%201%201'%3E%3C/svg%3E" data-src="https://cdn.cancerletter.com/media/2021/03/17053004/TCL-logo-horizontal-white.png" alt="" >

Vol.

31

No.

21

May 27, 2005May 27, 2005

Free

DOWNLOAD THE PDF

Combined analysis moves Herceptin to adjuvant setting in breast cancer.

Breast cancer session was ASCO equivalent of a rock concert, discussant says.

Avastin doubles progression-free survival in metastatic disease.

Also MQSA should require mammography facilities to gather data on interpretation, cancer policy board committee says.

Colorado universities install huge NMR magnet. NCI to transfer 5 A Day to CDC.

Recent Issues

Volume 52 | Issue 41 - November 06, 2026

Volume 52 | Issue 40 - October 30, 2026

Volume 52 | Issue 39 - October 23, 2026

Volume 52 | Issue 38 - October 16, 2026

Volume 52 | Issue 37 - October 09, 2026

Volume 52 | Issue 36 - October 02, 2026